Update on the treatment of Parkinson's disease.
D000547:Amantadine / Q000627:therapeutic use; D001971:Bromocriptine / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use; D002230:Carbidopa / Q000494:pharmacology; D004357:Drug Synergism; D006801:Humans; D007980:Levodopa / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use; D010276:Parasympatholytics / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy* / Q000378:metabolism; D012642:Selegiline / Q000627:therapeutic use; D013997:Time Factors
D010276:Parasympatholytics; D012642:Selegiline; D001971:Bromocriptine; D007980:Levodopa; D000547:Amantadine; D002230:Carbidopa